Characterization of edible marijuana product exposures reported to United States poison centers

被引:68
|
作者
Cao, Dazhe [1 ]
Srisuma, Sahaphume [2 ]
Bronstein, Alvin C. [3 ,4 ,5 ]
Hoyte, Christopher O. [4 ,5 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Mahidol Univ, Ramathibodi Hosp, Div Clin Pharmacol & Toxicol, Ramathibodi Poison Ctr,Dept Med, Bangkok, Thailand
[3] Hawaii Dept Hlth, Emergency Med Serv Injury Prevent Syst Branch, Honolulu, HI USA
[4] Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, Denver, CO USA
[5] Univ Colorado, Dept Emergency Med, Anschutz Med Ctr, Sch Med, Aurora, CO USA
关键词
Epidemiology; toxicity; poison center; MEDICAL MARIJUANA; CANNABINOIDS; ASSOCIATION;
D O I
10.1080/15563650.2016.1209761
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Context: Edible marijuana products are sold as brownies, cookies, and candies, which may be indistinguishable from counterparts without marijuana and are palatable to children and adults. The consumption of an entire product containing multiple dose-units may result in overdose.Objective: To characterize edible marijuana exposures reported to US poison centers with subgroup analysis by age.Methods: We analyzed single substance, human exposure calls coded to marijuana brownies, candies, cookies, beverages, or other foods reported to the National Poison Data System from January 2013 to December 2015. Calls were analyzed by state, age, gender, exposure route, clinical effect, therapies, and level of healthcare facility utilization.Results: Four-hundred and thirty calls were reported: Colorado (N=166, 1.05/100,000 population/year) and Washington (96, 0.46) yielded the highest number of exposures. Three hundred and eighty-one (91%) calls occurred in states with decriminalized medical/recreational marijuana. The number of calls increased every year of the study. The most common age groups were: 5 years (N=109, 0.15/100,000 population/year) and 13-19 (78, 0.09). The most frequent clinical effects were drowsiness/lethargy (N=118, percentage=43%), tachycardia (84, 31%), agitated/irritable (37, 14%), and confusion (37, 14%). Children 5 years have more drowsiness/lethargy, ataxia, and red eye/conjunctivitis. No deaths were reported. The most common therapies administered were intravenous fluids (85, 20%), dilute/irrigate/wash (48, 11 %), and benzodiazepines (47, 11%). Three patients (ages 4, 10, and 57 years) received intubation. 97 (23%), 217 (50%), and 12 (3%) calls were managed at home, treated/released, admitted to a critical care unit, respectively.Discussion: Although most clinical effects are minor, ventilatory support may be necessary for children and adults. We speculate the increasing exposures may be related to a combination of delayed absorption kinetics of 9-tetrahydrocannablnol, lagging packaging regulations, increased accessibility in decriminalized states, and increased familiarity of poison center specialists with edible product codes.Conclusions: Edible marijuana exposures are increasing and may lead to severe respiratory depression.
引用
收藏
页码:840 / 846
页数:7
相关论文
共 50 条
  • [1] Marijuana exposures reported to the US Poison Centers
    Rege, Saumitra
    Goodrich, Will R.
    Holstege, Christopher P.
    [J]. CLINICAL TOXICOLOGY, 2023, 61 : 18 - 18
  • [2] Exposures in pregnant patients reported to United States Poison Centers
    Leonard, James B.
    Minhaj, Faisal S.
    Paterson, Emily
    Klein-Schwartz, Wendy
    [J]. CLINICAL TOXICOLOGY, 2022, 60 (03) : 356 - 361
  • [3] Ocular exposures reported to United States poison control centers
    Kamboj, Alisha
    Spiller, Henry
    Casavant, Marcel
    Chounthirath, Thitphalak
    Smith, Gary
    [J]. CLINICAL TOXICOLOGY, 2018, 56 (10) : 1030 - 1030
  • [4] Ocular Exposures Reported to United States Poison Control Centers
    Kamboj, Alisha
    Spiller, Henry A.
    Casavant, Marcel J.
    Chounthirath, Thitphalak
    Smith, Gary A.
    [J]. OPHTHALMIC EPIDEMIOLOGY, 2019, 26 (02) : 84 - 94
  • [5] Synthetic cannabinoid and marijuana exposures reported to poison centers
    Forrester, M. B.
    Kleinschmidt, K.
    Schwarz, E.
    Young, A.
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 2012, 31 (10) : 1006 - 1011
  • [6] Characterization of intentional-abuse venlafaxine exposures reported to poison control centers in the United States
    Leonard, James B.
    Klein-Schwartz, Wendy
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04): : 421 - 426
  • [7] Phenibut Exposures Reported to Poison Centers - United States, 2009-2019
    Graves, Janessa M.
    Dilley, Julia
    Kubsad, Sanjay
    Liebelt, Erica
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (35): : 1227 - 1228
  • [8] Trends in chlorine and chloramine gas exposures reported to United States poison centers
    Atalla, Anthony
    Shulman, Joshua
    Rose, Jason
    Lynch, Michael
    [J]. CLINICAL TOXICOLOGY, 2024, 62 (09) : 589 - 595
  • [9] Organophosphate exposures in the United States: A longitudinal analysis of incidents reported to poison centers
    Sudakin, Daniel L.
    Power, Laura E.
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2007, 70 (02): : 141 - 147
  • [10] METHAMPHETAMINE EXPOSURES REPORTED TO UNITED STATES POISON CONTROL CENTERS, 2000-2019
    Chen, T.
    Spiller, H.
    Badeti, J.
    Funk, A.
    Zhu, M.
    Smith, G.
    [J]. INJURY PREVENTION, 2021, 27 : A6 - A6